These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25298033)

  • 1. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.
    Schurgers LJ; Spronk HM
    Thromb Haemost; 2014 Nov; 112(5):909-17. PubMed ID: 25298033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials.
    Vanassche T; Hirsh J; Eikelboom JW; Ginsberg JS
    Thromb Haemost; 2014 Nov; 112(5):918-23. PubMed ID: 25187203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anticoagulants for stroke prevention in patients with atrial fibrillation.
    Jalota A; Scarabelli TM; Saravolatz L; Bakhsh MU; Agrawal P; Jalota R; Chen-Scarabelli C; Fuster V; Halperin J
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):247-62. PubMed ID: 24842559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L; Mondoly P; Duparc A; Bura-Rivière A; Maury P; Calmels V; Sallerin B; Pathak A; Montastruc JL; Bagheri H
    Therapie; 2015; 70(6):485-92. PubMed ID: 26223162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent changes in practice guidelines for atrial fibrillation management.
    Charneski L; Hollands JM
    Pharmacotherapy; 2014 Nov; 34(11):1118-20. PubMed ID: 25284056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment with oral anticoagulants in older patients: Should warfarin still be prescribed?].
    Lafuente-Lafuente C; Oasi C; Belmin J
    Presse Med; 2019 Feb; 48(2):154-164. PubMed ID: 30528147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs).
    van Gorp RH; Schurgers LJ
    Nutrients; 2015 Nov; 7(11):9538-57. PubMed ID: 26593943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream versus downstream thrombin inhibition.
    Gulpen AJ; Ten Cate-Hoek AJ; Ten Cate H
    Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1273-1282. PubMed ID: 27575701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new era for oral anticoagulation? Old and new anticoagulant drugs.
    Verhamme P; Verhaeghe R
    Acta Cardiol; 2007 Apr; 62(2):189-98. PubMed ID: 17536609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New oral anticoagulants: their role in stroke prevention in high-risk patients with atrial fibrillation.
    Ferns SJ; Naccarelli GV
    Med Clin North Am; 2015 Jul; 99(4):759-80. PubMed ID: 26042881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When do patients prefer a direct oral anticoagulant over a vitamin K antagonist?
    Boom MS; Berghuis EM; Nieuwkerk PT; Pinedo S; Büller HR
    Neth J Med; 2015 Oct; 73(8):368-72. PubMed ID: 26478546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effective, safe stroke prevention with novel oral anticoagulants in patients with atrial fibrillation. Focus on dabigatran].
    Szapary L; Fehér G; Bosnyák E; Deli G; Csécsei P
    Ideggyogy Sz; 2013 May; 66(5-6):165-74. PubMed ID: 23909016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants.
    Weitz JI; Pollack CV
    Thromb Haemost; 2015 Nov; 114(6):1113-26. PubMed ID: 26155974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants: to switch or not to switch?
    Lugthart S; Leebeek FW
    Neth J Med; 2015 Oct; 73(8):359-61. PubMed ID: 26478544
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization.
    Khachatryan T; Hauschild C; Hoff J; Contractor T; Khachatryan A; Tran H; Matsuo B; Jacobson A; Hilliard A
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):525-539. PubMed ID: 30941708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.
    Galanis T; Merli GJ
    Hosp Pract (1995); 2013 Feb; 41(1):26-36. PubMed ID: 23466965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to emergent reversal.
    Gehrie E; Tormey C
    Arch Pathol Lab Med; 2015 May; 139(5):687-92. PubMed ID: 25927153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.